{"id":80978,"date":"2013-04-16T16:28:00","date_gmt":"2013-04-16T16:28:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=80978"},"modified":"2026-04-03T11:54:38","modified_gmt":"2026-04-03T11:54:38","slug":"afacerile-globale-ale-roche-cresc-cu-6-dupa-primul-trimestru","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=80978","title":{"rendered":"Afacerile globale ale Roche cresc cu 6% dup\u0103 primul trimestru"},"content":{"rendered":"<p>\nDe asemenea, lansarea cu success a dou\u0103 noi molecule destinate cancerului de s\u00e2n \u00een Statele Unite \u015fi \u00een Europa, a constituit un vector important de cre\u015ftere.<\/p>\n<p>\n\u201eAm \u00eenceput anul 2013 \u00een for\u0163\u0103 datorit\u0103 unei cre\u015fteri organice sus\u0163inute. Lansarea \u00een Statele Unite \u015fi Europa a celor dou\u0103 noi medicamente destinate trat\u0103rii cancerului de s\u00e2n ne va ajuta s\u0103 ne \u00eembun\u0103t\u0103\u0163im pozi\u0163ia de lider pe pia\u0163a produselor oncologice. Lu\u00e2nd \u00een considerare rezultatele financiare \u00eenregistrate \u00een primul trimestru al anului 2013 am \u00eencredere c\u0103 ne vom \u00eendeplini obiectivele pentru \u00eentreg anul\u201d, a declarat Severin Schwan, CEO al Roche.<\/p>\n<p>\nPentru anul 2013, Grupul Roche estimeaz\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor intr-un ritm similar cu cel \u00eenregistrat \u00een anul 2012, la o rat\u0103 de schimb constant\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grupul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor globale \u00een primul trimestru al anului 2013, cu 6% la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 11,6 miliarde franci elve\u0163ieni, datorit\u0103 cererii crescute pentru produsele oncologice \u015fi testele de diagnostic pentru laboratoarele clinice. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[81,246,8623],"class_list":["post-80978","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-afaceri","tag-crestere","tag-roche"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/80978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=80978"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/80978\/revisions"}],"predecessor-version":[{"id":94020,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/80978\/revisions\/94020"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=80978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=80978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=80978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}